David M. Demski's most recent trade in Axonics Inc was a trade of 10,000 Stock Options (Right to buy) done . Disclosure was reported to the exchange on Nov. 15, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axonics Inc | David M. Demski | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2024 | 10,000 | 0 | - | - | Stock Options (Right to buy) | |
| Axonics Inc | David M. Demski | Director | Sale or transfer of securities back to the company at price $ 71.00 per share. | 15 Nov 2024 | 9,542 | 0 (0%) | 0% | 71 | 677,482 | Common Stock |
| Axonics Inc | David M. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 3,000 | 9,542 (0%) | 0% | 0 | Common Stock | |
| Axonics Inc | David M. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2022 | 2,100 | 6,542 (0%) | 0% | 0 | Common Stock | |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Axonics Inc | David M. Demski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Oct 2021 | 942 | 4,442 (0%) | 0% | 0 | Common Stock | |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 71.50 per share. | 23 Apr 2021 | 144,263 | 0 (0%) | 0% | 71.5 | 10,314,805 | Class A Common Stock |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Sale of securities on an exchange or to another person at price $ 71.59 per share. | 23 Apr 2021 | 121,259 | 0 (0%) | 0% | 71.6 | 8,680,932 | Class A Common Stock |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 78,334 | 0 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.27 per share. | 23 Apr 2021 | 78,334 | 78,334 (0%) | 0% | 26.3 | 2,057,834 | Class A Common Stock |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 65,929 | 31,250 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.31 per share. | 23 Apr 2021 | 65,929 | 144,263 (0%) | 0% | 29.3 | 1,932,379 | Class A Common Stock |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 54,688 | 120,312 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 53.27 per share. | 23 Apr 2021 | 54,688 | 121,259 (0%) | 0% | 53.3 | 2,913,230 | Class A Common Stock |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 22,821 | 97,179 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.31 per share. | 23 Apr 2021 | 22,821 | 66,571 (0%) | 0% | 29.3 | 668,884 | Class A Common Stock |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.77 per share. | 23 Apr 2021 | 21,875 | 21,875 (0%) | 0% | 43.8 | 957,469 | Class A Common Stock |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 21,875 | 65,625 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Apr 2021 | 21,875 | 28,125 | - | - | Stock Option (Right to Buy Class A Common Stock) | |
| Globus Medical Inc (Class A) | David M. Demski | Director, President, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.58 per share. | 23 Apr 2021 | 21,875 | 43,750 (0%) | 0% | 43.6 | 953,313 | Class A Common Stock |